logo
Plus   Neg
Share
Email

Teva Launches QVAR RediHaler - Quick Facts

Teva Pharmaceutical Industries Ltd. (TEVA) announced that QVAR RediHaler (beclomethasone dipropionate HFA) Inhalation Aerosol is now commercially available to patients in both 40 mcg and 80 mcg strengths by prescription in the U.S. With the launch of QVAR RediHaler, the company is discontinuing sales of the previously available QVAR.

QVAR RediHaler is the first and only breath-actuated aerosol inhaled corticosteroid for the maintenance treatment of asthma as a prophylactic therapy in patients 4 years of age and older.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Chinese e-commerce giant Alibaba Group Holding Limited and rival JD.com have set new sales records for the "Singles Day" online shopping event. Alibaba said Sunday that it generated gross merchandise volume or GMV of 213.5 billion yuan, or $30.8 billion on November 11, 2018, representing an increase of 27 percent compared to 2017. The Singles Day shopping festival began in 2009. Japanese conglomerate SoftBank Group Corp. said Monday it has received approval from the Tokyo Stock Exchange for listing of common stock of its Japanese mobile telecoms unit, SoftBank Corp. SoftBank plans to sell shares worth 2.4 trillion yen, or $21 billion, in its domestic mobile telecom unit. This would make it the world's biggest IPO after Alibaba's $25 billion IPO in 2014. Shares of Infineon Technologies AG were losing around 4 percent in the morning trading in Germany after the semiconductor solutions company reported Monday weak net profit in its fourth quarter. Income from continuing operations, however, grew with strong revenue growth. The company also increased its full-year dividend.
Follow RTT